Literature DB >> 9072571

Treatment of advanced bladder cancer with combined preoperative irradiation and radical cystectomy versus radical cystectomy alone: a phase III intergroup study.

J A Smith1, E D Crawford, J C Paradelo, B Blumenstein, B R Herschman, H B Grossman, D W Christie.   

Abstract

PURPOSE: Our study was designed to compare the effects of preoperative irradiation and cystectomy to surgery alone in patients with transitional cell carcinoma of the bladder.
MATERIALS AND METHODS: A total of 140 patients with documented invasive bladder cancer or rapidly recurring superficial high grade tumors was randomized to receive 2,000 rad of pelvic irradiation followed by cystectomy within 1 week or surgery alone.
RESULTS: The 5-year survival rate was 53% (95 confidence intervals 41 to 65%) in the surgery only group and 43% (95% confidence intervals 30 to 56%) in the irradiation plus surgery group. The p value for the log rank statistic comparing the survival distributions was 0.23.
CONCLUSIONS: Although this trial showed no benefit for preoperative irradiation and cystectomy, the confidence intervals were wide. This finding does not exclude the possibility of a favorable effect of radiation in a subset of patients with high stage tumors. Overall, however, the dominant effect of distant disease as a cause of treatment failure diminishes any potential impact of radiation on results.

Entities:  

Mesh:

Year:  1997        PMID: 9072571

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

1.  [Preoperative radiotherapy in bladder carcinoma].

Authors:  J Dunst
Journal:  Strahlenther Onkol       Date:  1998-03       Impact factor: 3.621

Review 2.  Radiotherapy with radical cystectomy for bladder cancer: A systematic review and meta-analysis.

Authors:  Kristen Mcalpine; Dean A Fergusson; Rodney H Breau; Luke F Reynolds; Risa Shorr; Scott C Morgan; Libni Eapen; Ilias Cagiannos; Chris Morash; Luke T Lavallée
Journal:  Can Urol Assoc J       Date:  2018-05-28       Impact factor: 1.862

Review 3.  Bladder cancer: a review of diagnosis and management.

Authors:  M C Metts; J C Metts; S J Milito; C R Thomas
Journal:  J Natl Med Assoc       Date:  2000-06       Impact factor: 1.798

4.  Race reporting and disparities regarding clinical trials in bladder cancer: a systematic review.

Authors:  Elliott Freudenburg; Iyla Bagheri; Sunay Srinivas; Ariza Martinez; Nagireddy Putluri; Zachary Klaassen; Ashish M Kamat; Badrinath R Konety; William Y Kim; Lars Dyrskjøt; David J McConkey; Stephen J Freedland; Peter C Black; Siamak Daneshmand; James W F Catto; Stephen B Williams
Journal:  Cancer Causes Control       Date:  2022-06-14       Impact factor: 2.532

Review 5.  Contemporary management of muscle-invasive bladder cancer.

Authors:  Marc A Dall'Era; Liang Cheng; Chong-Xian Pan
Journal:  Expert Rev Anticancer Ther       Date:  2012-07       Impact factor: 4.512

Review 6.  Radiation therapy in urinary cancer: state of the art and perspective.

Authors:  M Troiano; P Corsa; A Raguso; S Cossa; M Piombino; G Guglielmi; S Parisi
Journal:  Radiol Med       Date:  2008-12-11       Impact factor: 3.469

7.  The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder.

Authors:  T Qayyum; G Fyffe; M Duncan; P A McArdle; M Hilmy; C Orange; G Halbert; M Seywright; P G Horgan; M A Underwood; J Edwards
Journal:  Br J Cancer       Date:  2012-02-21       Impact factor: 7.640

8.  Role of systemic peri-operative chemotherapy in management of transitional cell carcinoma of bladder.

Authors:  Rishi Nayyar; Narmada P Gupta
Journal:  Indian J Urol       Date:  2011-04

9.  Treatment of locally advanced and metastatic bladder cancer.

Authors:  Makarand V Khochikar
Journal:  Indian J Urol       Date:  2008-01

10.  Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer.

Authors:  S A Hussain; D D Stocken; D R Peake; J G Glaholm; A Zarkar; D M A Wallace; N D James
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.